Pleiotropic microenvironment remodeling micelles for cerebral ischemia-reperfusion injury therapy by inhibiting neuronal ferroptosis and glial overactivation
This specialised multi-peptide formulation combines BPC-157, TB-500, and GHK-Cu , supplied as a freeze-dried (lyophilised) powder to ensure stability, precision, and reproducibility in controlled scientific environments
Preclinical research in animal models shows that BPC-157 protects against NSAID-induced gastric ulcers, chemically induced intestinal lesions, and stress-related gut injuries, improving mucosal integrity and reducing symptoms such as abdominal pain, bloating, and diarrhea
Food & Drug Administration (2025) Your guide to FDA-approved medicines that contain semaglutide, Novo Nordisk FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, U.S